We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
General content - Editorial

Will gene–environment interactions explain differential antidepressant response?

    Robert Keers

    Forensic Psychiatry Research Unit, Barts & The London School of Medicine & Dentistry, William Harvey House, 61 Bartholomew Close, London EC1A 7BE, UK.

    Published Online:https://doi.org/10.2217/pme.12.28
    Free first page

    References

    • Trivedi MH, Rush AJ, Wisniewski SR et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry163(1),28–40 (2006).
    • Steimer W, Muller B, Leucht S, Kissling W. Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy. Clin. Chim. Acta308(1–2),33–41 (2001).
    • Franchini L, Serretti A, Gasperini M, Smeraldi E. Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees. J. Psychiatr. Res.32(5),255–259 (1998).
    • Keers R, Aitchison KJ. Pharmacogenetics of antidepressant response. Exp. Rev. Neurother.11(1),101–125 (2011).
    • Zou YF, Wang F, Feng XL et al. Meta-analysis of FKBP5 gene polymorphisms association with treatment response in patients with mood disorders. Neurosci. Lett.484(1),56–61 (2011).
    • Taylor MJ, Sen S, Bhagwagar Z. Antidepressant response and the serotonin transporter gene-linked polymorphic region. Biol. Psychiatry68(6),536–543 (2010).
    • Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group. J. Affect. Disord.18(4),289–299 (1990).
    • Keers R, Uher R, Gupta B et al. Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP. J. Affect. Disord.127(1–3),337–342 (2010).
    • Horacek J, Rozehnalova E, Rosslerova H, Dvorak A. The influence of stressful life events on development of depression and treatment response in the population of patients in higher age. Ceska Slovenska Psychiatr.106(5),311–317 (2011).
    • 10  Monroe SM, Kupfer DJ, Frank E. Life stress and treatment course of recurrent depression: 1. Response during index episode. J. Consult. Clin. Psychol.60(5),718–724 (1992).
    • 11  Bock C, Bukh JD, Vinberg M, Gether U, Kessing LV. Do stressful life events predict medical treatment outcome in first episode of depression? Soc. Psychiatry Psychiatry Epidemiol.44(9),752–760 (2009).
    • 12  Rutter M, Thapar A, Pickles A. Gene–environment interactions: biologically valid pathway or artifact? Arch. Gen. Psychiatry66(12),1287–1289 (2009).
    • 13  Uher R, McGuffin P. The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol. Psychiatry15(1),18–22 (2010).
    • 14  Keers R, Uher R. Gene–environment interaction in major depression and antidepressant treatment response. Curr. Psychiatry Rep.14(2),129–137 (2012).
    • 15  Mandelli L, Marino E, Pirovano A et al. Interaction between SERTPR and stressful life events on response to antidepressant treatment. Eur. Neuropsychopharmacol.19(1),64–67 (2009).
    • 16  Bukh JD, Bock C, Vinberg M, Werge T, Gether U, Kessing LV. No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment. Eur. Neuropsychopharmacol.20(5),327–335 (2010).
    • 17  Keers R, Uher R, Huezo-Diaz P et al. Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project. Pharmacogenom. J.11(2),138–145 (2011).
    • 18  Nanni V, Uher R, Danese A. Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. Am. J. Psychiatry169(2),141–151 (2011).
    • 19  Eley TC, Hudson JL, Creswall C et al. Therapygenetics: the 5HTTLPR and response to psychological therapy. Mol. Psychiatry17(3),236–237 (2012).